TY - JOUR
T1 - Neurodevelopmental outcomes at age 3 years of preterm infants born at 22–31 weeks’ gestation
AU - on behalf of the INTACT Study Group
AU - Kono, Yumi
AU - Kusuda, Satoshi
AU - Nishida, Toshihiko
AU - Mori, Rintaro
AU - Toyoshima, Katsuaki
AU - Sasaki, Hatoko
AU - Yonemoto, Naohiro
AU - Uchiyama, Atsushi
AU - Fujimura, Masanori
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2025.
PY - 2025
Y1 - 2025
N2 - Objective: To evaluate neurodevelopmental outcomes of very preterm infants by gestational age (GA) using high follow-up rate data. Study design: This secondary analysis included infants born before 32 weeks’ gestation in 2012–2014 from the Improvement of NICU practices and Team Approach Cluster randomized controlled Trial (INTACT). The primary outcome was survival without moderate or severe neurodevelopmental impairment (NDI). Results: Among 2722 infants, NICU survival rate was 96.5%, ranging 72.1–99.6% at 22–31 weeks. At age three years, 2336 (89.5% of 2610 survivors) were completely assessed; 303 had moderate NDI and 183 had severe NDI. Of these, the proportions of infants surviving without NDI increased with GA; 45.2% at 22 weeks, 57.5% at 23 weeks, 88.1% at 31 weeks. Conclusion: Although survival without NDI varied by GA, more than half (55.0%, 83/151) of infants born at 22–23 weeks who survived to age three years were without neurodevelopmental sequelae.
AB - Objective: To evaluate neurodevelopmental outcomes of very preterm infants by gestational age (GA) using high follow-up rate data. Study design: This secondary analysis included infants born before 32 weeks’ gestation in 2012–2014 from the Improvement of NICU practices and Team Approach Cluster randomized controlled Trial (INTACT). The primary outcome was survival without moderate or severe neurodevelopmental impairment (NDI). Results: Among 2722 infants, NICU survival rate was 96.5%, ranging 72.1–99.6% at 22–31 weeks. At age three years, 2336 (89.5% of 2610 survivors) were completely assessed; 303 had moderate NDI and 183 had severe NDI. Of these, the proportions of infants surviving without NDI increased with GA; 45.2% at 22 weeks, 57.5% at 23 weeks, 88.1% at 31 weeks. Conclusion: Although survival without NDI varied by GA, more than half (55.0%, 83/151) of infants born at 22–23 weeks who survived to age three years were without neurodevelopmental sequelae.
UR - http://www.scopus.com/inward/record.url?scp=105002056474&partnerID=8YFLogxK
U2 - 10.1038/s41372-025-02268-3
DO - 10.1038/s41372-025-02268-3
M3 - 学術論文
AN - SCOPUS:105002056474
SN - 0743-8346
JO - Journal of Perinatology
JF - Journal of Perinatology
M1 - e20171264
ER -